Abstract IA10: DNA repair mutations in ovarian carcinoma and relationship to therapeutic response

Ovarian carcinomas with germline or somatic mutations in BRCA1 and BRCA2 are sensitive to platinum chemotherapy and to PARP inhibitors. The therapeutic role of damaging mutations in other homologous recombination genes is less certain. We will review various measures of homologous recombination deficiency in ovarian cancer and their correlation with efficacy of PARP inhibitor therapy in the relapsed setting.Citation Format: Elizabeth M. Swisher. DNA repair mutations in ovarian carcinoma and relationship to therapeutic response [abstract]. In: Proceedings of the AACR Special Conference on DNA Repair: Tumor Development and Therapeutic Response; 2016 Nov 2-5; Montreal, QC, Canada. Philadelphia (PA): AACR; Mol Cancer Res 2017;15(4_Suppl):Abstract nr IA10.
Source: Molecular Cancer Research - Category: Cancer & Oncology Authors: Tags: DNA Repair Gene Mutations in Cancer Genomes: Oral Presentations - Invited Abstracts Source Type: research